David Hung Insider Profile

11 Followers
David Hung, President & CEO, Director at Medivation, holds 13.19K shares in NovoCure (Ticker: NVCR), holds 58.28M shares in Nuvation Bio (Ticker: NUVB), holds 0.00 shares in Sio Gene Therapies (Ticker: SIOX).
tipranks
David Hung

David Hung
Medivation (MDVN)
President & CEO, Director

Ranked #74,821 out of 98,042 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-35.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$215M
99.89%
0.11%
0.00%
A breakdown of David Hung's holdings

Insider Roles

Nuvation Bio
(NUVB)
President & CEO, Director, Ten Percent Owner
NovoCure
(NVCR)
Director
Establishment Labs Holdings
(ESTA)
Director
Roles that David Hung holds in companies

Most Profitable Insider Trade

Stock:
Medivation
(MDVN)
Rating:Informative Sell
Date:Dec 04, 2014 - Dec 04, 2015
Return:+24.40%
The most profitable trade made by David Hung

David Hung's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MDVN
Medivation
Sep 30, 2016
Uninformative Sell
$133.32M
SIOX
Sio Gene Therapies
Apr 19, 2017
Informative Buy
10.00M
$0.00
NovoCure
Jun 06, 2024
Director
Uninformative Buy
$246.07K
Establishment Labs Holdings
Director
~ARYA
ARYA Sciences Acquisition
Nuvation Bio
Mar 02, 2023
President & CEO, Director, Ten Percent Owner
Uninformative Sell
$215.06M
ACER
Acer Therapeutics
Sep 10, 2009
Informative Sell
84.44K
$0.00
List of latest transactions for each holding click on a transaction to see David Hung's performance on stock

David Hung insider profile FAQ

What is the percentage of profitable transactions made by David Hung?
The percentage of profitable transactions made by David Hung is 50%.
    What is the average return per transaction made by David Hung?
    The average return per transaction made by David Hung is -35.20%.
      What stocks does David Hung hold?
      David Hung holds: MDVN, SIOX, NVCR, ESTA, ~ARYA, NUVB, ACER stocks.
        What was David Hung’s latest transaction?
        David Hung latest transaction was an Uninformative Buy of ―.
          What was David Hung's most profitable transaction?
          David Hung’s most profitable transaction was an Informative Sell of MDVN stock on December 4, 2014. The return on the trade was 24.40%.
            What is David Hung's role in Medivation?
            David Hung's role in Medivation is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.